X4 Pharmaceuticals, Inc. buy Cantor Fitzgerald
Start price
31.05.24
/
50%
€0.93
Target price
31.05.25
€4.61
Performance (%)
-82.01%
End price
01.06.25
-
Summary
This prediction is currently being closed. Massive losses of -82.01% have been the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has a follow-up prediction for X4 Pharmaceuticals, Inc. where he still thinks X4 Pharmaceuticals, Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | - | - | - |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% |
Comments by Cantor_Fitzgerald for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat
In the thread Trading X4 Pharmaceuticals, Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.25
26.03.25
26.03.25
€2.78
26.03.26
26.03.26
-33.95%
25.04.25
25.04.25
